| Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation JU Peled, ALC Gomes, SM Devlin, ER Littmann, Y Taur, AD Sung, ... New England Journal of Medicine 382 (9), 822-834, 2020 | 522 | 2020 |
| Lactose drives Enterococcus expansion to promote graft-versus-host disease CK Stein-Thoeringer, KB Nichols, A Lazrak, MD Docampo, ... Science 366 (6469), 1143-1149, 2019 | 263 | 2019 |
| Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy M Smith, A Dai, G Ghilardi, KV Amelsberg, SM Devlin, R Pajarillo, ... Nature medicine 28 (4), 713-723, 2022 | 156 | 2022 |
| The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD KA Markey, J Schluter, ALC Gomes, ER Littmann, AJ Pickard, BP Taylor, ... Blood, The Journal of the American Society of Hematology 136 (1), 130-136, 2020 | 111 | 2020 |
| Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition MJ Pianko, SM Devlin, ER Littmann, A Chansakul, D Mastey, M Salcedo, ... Blood advances 3 (13), 2040-2044, 2019 | 61 | 2019 |
| Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study N Khan, S Lindner, ALC Gomes, SM Devlin, GL Shah, AD Sung, ... Blood, The Journal of the American Society of Hematology 137 (11), 1527-1537, 2021 | 47 | 2021 |
| Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease M Burgos da Silva, DM Ponce, A Dai, S M. Devlin, ALC Gomes, G Moore, ... Blood, The Journal of the American Society of Hematology 140 (22), 2385-2397, 2022 | 34 | 2022 |
| Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant O Miltiadous, NR Waters, H Andrlová, A Dai, CL Nguyen, ... Blood, The Journal of the American Society of Hematology 139 (18), 2758-2769, 2022 | 31 | 2022 |
| MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT H Andrlová, O Miltiadous, AI Kousa, A Dai, S DeWolf, S Violante, HY Park, ... Science translational medicine 14 (646), eabj2829, 2022 | 24 | 2022 |
| Conditioning regimens are associated with distinct patterns of microbiota injury in allogeneic hematopoietic cell transplantation R Shouval, NR Waters, ALC Gomes, C Zuanelli Brambilla, T Fei, ... Clinical Cancer Research 29 (1), 165-173, 2023 | 23 | 2023 |
| Intestinal microbiota composition prior to car t cell infusion correlates with efficacy and toxicity M Smith, ER Littmann, JB Slingerland, A Clurman, AE Slingerland, Y Taur, ... Blood 132, 3492, 2018 | 15 | 2018 |
| High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients CL Nguyen, KA Markey, O Miltiadous, A Dai, N Waters, K Sadeghi, T Fei, ... Cell 186 (12), 2705-2718. e17, 2023 | 14 | 2023 |
| Intestinal microbiome analyses identify biomarkers for patient response to CAR T cell therapy M Smith, E Littmann, J Slingerland, A Clurman, AE Slingerland, Y Taur, ... Biology of Blood and Marrow Transplantation 25 (3), S177, 2019 | 9 | 2019 |
| Loss of microbiota diversity after autologous stem cell transplant is comparable to injury in allogeneic stem cell transplant N Khan, JU Peled, ALC Gomes, SM Devlin, C Rondon-Clavo, A Clurman, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 7 | 2018 |
| Pre-transplant fecal microbial diversity independently predicts critical illness after hematopoietic cell transplantation FI Adhi, ER Littmann, Y Taur, MA Maloy, KA Markey, E Fontana, ... Blood 134, 3264, 2019 | 5 | 2019 |
| Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy M Smith, A Dai, G Ghilardi, KV Amelsberg, SM Devlin, R Pajarillo, ... Nature medicine 29 (11), 2954-2954, 2023 | 4 | 2023 |
| Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal … S Chhabra, A Szabo, A Clurman, K McShane, N Waters, D Eastwood, ... Haematologica 108 (1), 250, 2023 | 4 | 2023 |
| The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies M Smith, A Dai, G Ghilardi, K Amelsberg, SM Devlin, R Pajarillo, ... Blood 138, 253, 2021 | 3 | 2021 |
| Intestinal Microbiota Composition Is Associated with Minimal Residual Disease Negativity in Patients with Multiple Myeloma MJ Pianko, SM Devlin, ER Littmann, A Chansakul, D Mastey, M Salcedo, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 3 | 2018 |
| MAIT and Vδ2 Unconventional T Cells Predict Favorable Outcome after Allogeneic HCT and Are Supported By a Diverse Intestinal Microbiome H Andrlova, O Miltiadous, A Dai, R Gardner, S El Daker, JB Slingerland, ... Blood 138, 331, 2021 | 2 | 2021 |
